Cardio Diagnostics Holdings, Inc.
CDIOW- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $139.7K in total; no superinvestor holds it.
Other share classesCDIO
Q1 2023 vs. Q4 2022
How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 21 | 16 | −5 |
| Shares | 1.53M | 1.31M | −212.8K (−13.9%) |
| Value | $66.9K | $400.2K | +$333.3K (+498.6%) |
New holders (3)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Clear Street LLC | 87,107 | $27.9K | 0.00% |
| Context Capital Management, LLC | 81,500 | $26.0K | 0.00% |
| Virtu Financial LLC | 15,469 | $5.00K | 0.00% |
Sold out (8)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| K2 Principal Fund, L.P. | 92,500 | $4.58K |
| Polar Asset Management Partners Inc. | 89,943 | $4.33K |
| Shaolin Capital Management LLC | 47,000 | $2.00K |
| Wolverine Asset Management LLC | 29,959 | $1.48K |
| Gabelli Funds LLC | 26,290 | $1.30K |
| Gabelli & Co Investment Advisers, Inc. | 22,410 | $1.11K |
| Susquehanna International Group, LLP | 12,483 | $618 |
| Radcliffe Capital Management, L.P. | 50,000 | – |